CapEdge
Loading...
Advanced
What's new? Log in Free sign up
  • Home
  • Sectors & IndustriesSectors
  • Earnings
  • IPOs
  • SPACs
  • Transcripts
  • Insider
  • Institutional
  • Crypto
  • Screeners
  • Reddit
  • Splits
  • NOAC Dashboard
  • Financials
  • Filings
  • ETFs
  • Insider
  • Institutional
  • Shorts
  • News
  • Reddit
  • 8-K Filing

Natural Order Acquisition (NOAC) 8-KEntry into a Material Definitive Agreement

Filed: 13 Nov 20, 5:28pm
Free signup for more
  • Track your favorite companies
  • Receive email alerts for new filings
  • Personalized dashboard of news and more
  • Access all data and search results
Sign up for free
Search this filing
?
Pre-defined:
Table of contents
    Filing tables
    Export all tables to Excel
    Filing exhibits
    SEC
    • 8-K Current report
    • 1.1 Underwriting Agreement, Dated November 10, 2020, by and Among the Registrant, Chardan Cpital Markest LLC, Barclays Cpaital Inc., As Representatives of Underwriters
    • 3.2 Amended and Restated Certificate of Incorporation of the Company
    • 10.1 Letter Agreement, Dated November 10, 2020 by and Among the Registrant and Its Officers, Directors and Initial Stockholders
    • 10.2 Investment Management Trust Agreement, Dated November 10, 2020 by and Among the Registrant and Continental Stock Transfer & Trust Company, LLC As Trustee
    • 10.3 Escrow Agreement, Dated November 10, 2020, by and Among the Registrant, Continental Stock Transfer & Trust Company LLC, As Escrow Agent and the Registrant's Initial Stockholders
    • 10.4 Registration Rights Agreement, Dated November 10, 2020 by and Among Registrant and the Registrant's Initial Stockholders
    • 10.5 Subscription Agreement, Dated November 10, 2020 by and Between the Registrant and the Sponsor
    • 10.6 Administrative Support Agreement, Dated November 10, 2020 by and Between the Registrant and the Sponsor
    • 10.7 Indemnity Agreement, Each Dated November 10, 2020 by and Between the Registrant and Each of the Registrant's Officers and Directors
    • 99.1 Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Other Events; Financial Statements and Exhibits
    NOAC similar filings
    • 18 May 21 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
    • 26 Jan 21 Other Events
    • 19 Nov 20 Index to Financial Statement
    • 13 Nov 20 Entry into a Material Definitive Agreement
    Filing view
    Share this filing

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    Form 8-K

     

    Current Report
    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934

     

    November 10, 2020

    Date of Report (Date of earliest event reported)

     

    Natural Order Acquisition Corp.

    (Exact Name of Registrant as Specified in its Charter)

     

    Delaware 001-39690 85-2464911
    (State or other jurisdiction
    of incorporation)
     (Commission
    File Number)
     (I.R.S. Employer
    Identification No.)

     

    30 Colpitts Road, Weston, MA 02493
    (Address of Principal Executive Offices) (Zip Code)

     

    Registrant’s telephone number, including area code:  (617) 395-1644

    N/A

     

     

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐Written communications pursuant to Rule 425 under the Securities Act

     

    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act

     

    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

     

    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading Symbols Name of each exchange on which registered
    Units, each consisting of one share of common stock, $0.0001 par value (the “Common Stock”), and one Warrant NOACU The Nasdaq Stock Market LLC

     

    Common Stock included as part of the units

     NOAC The Nasdaq Stock Market LLC
    Warrants included as part of the units, each to receive one-half (1/2) of one share of Common Stock NOACW The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 1.01. Entry Into a Material Definitive Agreement

     

    On November 13, 2020, Natural Order Acquisition Corp. (the “Company”) consummated its initial public offering (the “IPO”) of 23,000,000 units (“Units”), with each Unit consisting of one share of common stock, par value $0.0001 per share (the “Common Stock”), and one warrant to purchase one-half of one share of Common Stock for $11.50 (the “Warrant”) which includes full exercise of the underwriter’s over-allotment option. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $230,000,000.

     

    In connection with the IPO, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Company’s Registration Statement on Form S-1 (File No. 333-249458) related to the IPO, originally filed with the U.S. Securities and Exchange Commission (the “Commission”) on October 13, 2020 (as amended, and including Amendment No. 1 to the Registration Statement filed on October 27, 2020, and Amendment No. 2 to the Registration Statement on November 5, 2020, the “Registration Statement”):

     

     ●Underwriting Agreement, dated November 10, 2020 by and among the Registrant, Chardan Capital Markets LLC, Barclays Capital Inc., as representatives of underwriters , a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference.

     

     ●Letter Agreement, dated November 10, 2020 by and among the Registrant and its officers, directors and initial stockholders, including Natural Order Sponsor LLC (the “Sponsor”), a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference.

      

     ●Investment Management Trust Agreement, dated November 10, 2020 by and among the Registrant and Continental Stock Transfer & Trust Company, LLC as trustee, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference.
       
     ●Escrow Agreement, dated November 10, 2020 by and among the Registrant, Continental Stock Transfer & Trust Company LLC, as escrow agent and the Registrant’s initial stockholders, a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference.
       
     ●Registration Rights Agreement, dated November 10, 2020 by and among Registrant and the Registrant’s initial stockholders, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference.  
       
     ●Subscription Agreement, dated November 10, 2020 by and between the Registrant and the Sponsor, a copy of which is attached as Exhibit 10.5 hereto and incorporated herein by reference.
       
     ●Administrative Support Agreement, dated November 10, 2020 by and between the Registrant and the Sponsor, a copy of which is attached as Exhibit 10.6 hereto and incorporated herein by reference.
       
     ●Indemnity Agreement, each dated November 10, 2020 by and between the Registrant and each of the Registrant’s officers and directors, a copy of which is attached as Exhibit 10.7 hereto and incorporated by reference.  

     

    Item 3.02 Unregistered Sales of Equity Securities

     

    Simultaneously with the closing of the IPO, the Company consummated the private placement (“Private Placement”) with the Sponsor of 6,800,000 Warrants (the “Private Warrants”) at a price of $1.00 per Private Warrant, generating total proceeds of $6,600,000, after repayment and cancellation of two outstanding promissory notes owed to Sponsor in the aggregate principal amount of $200,000.

     

    The Private Warrants are identical to the Warrants underlying the Units sold in the IPO except that if held by the Sponsor or its permitted transferees, they (i) may be exercised for cash or on a cashless basis, (ii) are not subject to being called for redemption and (iii) subject to certain limited exceptions including the Common Stock issuable upon exercise of the Private Warrants, will be subject to transfer restrictions until 30 days following the consummation of the Company's initial business combination. If the Private Warrants are held by holders other than the sponsor or its affiliates and permitted transferees, the Private Warrants will be redeemable by the Company in all redemption scenarios and exercisable by holders on the same basis as the Warrants sold in the IPO. The Private Warrants have been issued pursuant to the Subscription Agreement and the Private Warrants are governed by the Warrant Agreement. 

     

    The Private Warrants were issued pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, as the transactions did not involve a public offering.

     

    Item 5.03 Amendments to Certificate of Incorporation or Bylaws; Change in Fiscal Year

     

    On November 10, 2020, in connection with the IPO, the Company filed its Amended and Restated Certificate of Incorporation with the Delaware Secretary of State. The terms of the Amended and Restated Certificate of Incorporation are set forth in the Registration Statement and are incorporated herein by reference. A copy of the Company’s Amended and Restated Certificate of Incorporation is attached as Exhibit 3.2 hereto and is incorporated by reference herein.

     

    Item 8.01. Other Events

     

    As of November 13, 2020, a total of $230,000,000, including $8,050,000 of the underwriters’ deferred discount, of the net proceeds from the IPO and the Private Placement were deposited in a trust account established for the benefit of the Company’s public stockholders. An audited balance sheet as of November 13, 2020 reflecting receipt of the proceeds upon consummation of the IPO and the Private Placement will be filed within 4 business days of the consummation of the IPO. The Company issued a press release in connection with the closing of the IPO a copy of which is attached as Exhibit 99.1 hereto and incorporated by reference herein.

    1

     

     

    Item 9.01. Financial Statements and Exhibits

     

    (d)Exhibits.

     

    Exhibit No.  
       
    Ex. 1.1 Underwriting Agreement, dated November 10, 2020, by and among the Registrant, Chardan Cpital Markest LLC, Barclays Cpaital Inc., as representatives of underwriters
       
    Ex. 3.2 Amended and Restated Certificate of Incorporation of the Company
       
    Ex. 10.1 Letter Agreement, dated November 10, 2020 by and among the Registrant and its officers, directors and initial stockholders
       
    Ex. 10.2 Investment Management Trust Agreement, dated November 10, 2020 by and among the Registrant and Continental Stock Transfer & Trust Company, LLC as trustee
       
    Ex. 10.3 Escrow Agreement, dated November 10, 2020, by and among the Registrant, Continental Stock Transfer & Trust Company LLC, as escrow agent and the Registrant’s initial stockholders
       
    Ex. 10.4 Registration Rights Agreement, dated November 10, 2020 by and among Registrant and the Registrant’s initial stockholders
       
    Ex. 10.5 Subscription Agreement, dated November 10, 2020 by and between the Registrant and the Sponsor
       
    Ex. 10.6 Administrative Support Agreement, dated November 10, 2020 by and between the Registrant and the Sponsor
       
    Ex. 10.7 Indemnity Agreement, each dated November 10, 2020 by and between the Registrant and each of the Registrant’s officers and directors.
       
    Ex. 99.1 Press Release, dated November 13, 2020

     

    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: November 13, 2020 
      

    Natural Order Acquisition Corp.

     
       
    By:/s/ Paresh Patel 
    Name:Paresh Patel 
    Title:President and Chief Executive Officer 

     

     

     3

     

     

    Finsight
    Resources
    • Knowledgebase
    • Log In
    • Register
    Company
    • About
    • Contact
    • Solutions
    Products
    • Deal Roadshow
    • DealVDR
    • Evercall
    • Finsight.com
    CapEdge
    • Earnings Calendar
    • Earnings Transcripts
    • EDGAR Filing Screener
    • IPO Calendar
    • Compliance
    • Privacy
    • Security
    • Terms
    AngelList LinkedIn